TipRanks
55% OFF
PC:EXPRE

ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies is a biotechnology company specializing in the development of innovative vaccines and immunotherapies. Utilizing its clinically validated ExpreS2 platform, the company focuses on advancing a pipeline that includes a lead breast cancer vaccine currently in Phase I trials. Based in Hørsholm, Denmark, ExpreS2ion aims to deliver cutting-edge solutions to address unmet medical needs in the field of immunotherapy.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$12M
Total Funding Rounds
1
Latest Funding Amount
$12M
Latest Funding Round
Investment
Post-Money Valuation
―

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 08, 2025Investment$11.80M―

Investors

Investor NameFunding Round
Nils BergInvestment
UBB Consulting ABInvestment
John MollInvestment
Elvil ABInvestment
Paginera Invest ABInvestment
Peter NilssonInvestment

Similar Companies

A snapshot of private companies similar to ExpreS2ion Biotechnologies, helping you discover and navigate related company profiles.

Related News and Analysis